Trials / Terminated
TerminatedNCT00233558
Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
Multicentre, Randomised, Open Label Study Comparing a "Scheduled Steroid Reduction Strategy" Versus a Free Steroid Reduction Strategy (Physician's Usual Practice for Reducing Steroids) in Patients With Active RA Treated With Humira 40 mg Eow + MTX During 9 Months
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the clinical efficacy of scheduled versus free reduction of steroid treatment in patients with active RA treated with adalimumab + MTX
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adalimumab (up to 9 months exposure) | |
| DRUG | methotrexate |
Timeline
- Start date
- 2005-06-01
- First posted
- 2005-10-06
- Last updated
- 2007-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00233558. Inclusion in this directory is not an endorsement.